Compare Nuwellis Inc (NUWE) vs Prospect Capital Corporation (PSEC) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Nuwellis Inc vs Prospect Capital Corporation — how do they compare? Nuwellis Inc trades at $2.94 (market cap $1.09M), while Prospect Capital Corporation trades at $2.18 (market cap $1.12B). The key difference: Prospect Capital Corporation is far larger — about 1027.5× Nuwellis Inc's market cap, and Prospect Capital Corporation pays a 22.42% dividend while Nuwellis Inc pays none. Which is the better fit depends on your goals.
| NUWE | PSEC | |
|---|---|---|
Market Cap | $1.09M | $1.12B |
Sector | Technology | Financials |
52-Week High | $527.46 | $3.47 |
52-Week Low | $2.80 | $2.15 |
Enterprise Value | -$722.58K | — |
Dividend Yield | — | 22.42% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Nuwellis Inc
Nuwellis, Inc. is a medical device company focused on developing and commercializing fluid management solutions. The company's primary product is an ultrafiltration system used in hospitals to remove excess fluid from patients with fluid overload, often associated with conditions such as heart and kidney failure. Nuwellis aims to improve patient outcomes and reduce healthcare costs through its specialized, innovative therapies.
Read more on NUWE →About Prospect Capital Corporation
Prospect Capital Corp is a closed-end investment company based in the United States. Its investment objective is to generate both current income and long-term capital appreciation through debt and equity investments. The company invests primarily in senior and subordinated debt and equity of private companies for acquisitions, divestitures, growth, development, recapitalizations, and other purposes. It makes investments, including lending in private equity, sponsored transactions, directly to companies, investments in structured credit, real estate, and syndicated debt.
Read more on PSEC →
